Literature DB >> 16533426

Efficacy of polyphenon E, red ginseng, and rapamycin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice.

Ying Yan1, Yian Wang, Qing Tan, Yukihiko Hara, Taik-Koo Yun, Ronald A Lubet, Ming You.   

Abstract

The objective of this investigation was to determine the efficacy of several novel agents in preventing lung tumorigenesis in mice. We evaluated polyphenon E, red ginseng, and rapamycin in A/J mice treated with the tobacco-specific carcinogen benzo(a)pyrene for their ability to inhibit pulmonary adenoma formation and growth. We found that treatment with polyphenon E exhibited a significant reduction on both tumor multiplicity and tumor load (tumor multiplicity x tumor volume) in a dose-dependent fashion. Polyphenon E (2% wt/wt) in the diet reduced tumor multiplicity by 46% and tumor load by 94%. This result provided key evidence in support of a phase II clinical chemoprevention trial of lung cancer. Administration of red ginseng in drinking water decreased tumor multiplicity by 36% and tumor load by 70%. The mammalian target of rapamycin inhibitor rapamycin showed significant efficacy against lung tumor growth in the tumor progression protocol and reduced tumor load by 84%. The results of these investigations demonstrate that polyphenon E, red ginseng, and rapamycin significantly inhibit pulmonary adenoma formation and growth in A/J mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533426      PMCID: PMC1584290          DOI: 10.1593/neo.05652

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  49 in total

Review 1.  Panax ginseng--a non-organ-specific cancer preventive?

Authors:  T K Yun
Journal:  Lancet Oncol       Date:  2001-01       Impact factor: 41.316

Review 2.  The TOR pathway: a target for cancer therapy.

Authors:  Mary-Ann Bjornsti; Peter J Houghton
Journal:  Nat Rev Cancer       Date:  2004-05       Impact factor: 60.716

Review 3.  Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds.

Authors:  Taik-Koo Yun
Journal:  Mutat Res       Date:  2003 Feb-Mar       Impact factor: 2.433

Review 4.  Regulation of mammalian translation factors by nutrients.

Authors:  Christopher G Proud
Journal:  Eur J Biochem       Date:  2002-11

5.  Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions.

Authors:  W-S Ahn; J Yoo; S-W Huh; C-K Kim; J-M Lee; S-E Namkoong; S-M Bae; I P Lee
Journal:  Eur J Cancer Prev       Date:  2003-10       Impact factor: 2.497

Review 6.  The biology and clinical relevance of the PTEN tumor suppressor pathway.

Authors:  Isabelle Sansal; William R Sellers
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

7.  Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.

Authors:  H-H Sherry Chow; Yan Cai; Iman A Hakim; James A Crowell; Farah Shahi; Chris A Brooks; Robert T Dorr; Yukihiko Hara; David S Alberts
Journal:  Clin Cancer Res       Date:  2003-08-15       Impact factor: 12.531

8.  Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea.

Authors:  Jie Liao; Guang-Yu Yang; Eon Sub Park; Xiaofeng Meng; Yuhai Sun; Dongxuan Jia; Darren N Seril; Chung S Yang
Journal:  Nutr Cancer       Date:  2004       Impact factor: 2.900

9.  Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo.

Authors:  Kip A West; Ilona R Linnoila; Steven A Belinsky; Curtis C Harris; Phillip A Dennis
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

10.  Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.

Authors:  Hans-Guido Wendel; Elisa De Stanchina; Jordan S Fridman; Abba Malina; Sagarika Ray; Scott Kogan; Carlos Cordon-Cardo; Jerry Pelletier; Scott W Lowe
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

View more
  23 in total

1.  Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis.

Authors:  Xiangli Cui; Yu Jin; Deepak Poudyal; Alexander A Chumanevich; Tia Davis; Anthony Windust; Anne Hofseth; Wensong Wu; Joshua Habiger; Edsel Pena; Patricia Wood; Mitzi Nagarkatti; Prakash S Nagarkatti; Lorne Hofseth
Journal:  Carcinogenesis       Date:  2010-08-20       Impact factor: 4.944

2.  Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro.

Authors:  Qi Zhang; Jing Pan; Ronald A Lubet; Steven M Komas; Balaraman Kalyanaraman; Yian Wang; Ming You
Journal:  Cancer Prev Res (Phila)       Date:  2015-02-02

3.  The role of the Akt/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis.

Authors:  Regan M Memmott; Phillip A Dennis
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

4.  An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice.

Authors:  Ying Fu; Shana Silverstein; Justine N McCutcheon; Marcin Dyba; Raghu G Nath; Monika Aggarwal; Heidi Coia; Angela Bai; Jishen Pan; Jiji Jiang; Bhaskar Kallakury; Hongkun Wang; Yu-Wen Zhang; Giuseppe Giaccone; Aiwu Ruth He; Fung-Lung Chung
Journal:  Hepatology       Date:  2017-11-13       Impact factor: 17.425

5.  PHLPP2 Downregulation Contributes to Lung Carcinogenesis Following B[a]P/B[a]PDE Exposure.

Authors:  Haishan Huang; Xiaofu Pan; Honglei Jin; Yang Li; Lin Zhang; Caili Yang; Pei Liu; Ya Liu; Lili Chen; Jingxia Li; Junlan Zhu; Xingruo Zeng; Kai Fu; Guorong Chen; Jimin Gao; Chuanshu Huang
Journal:  Clin Cancer Res       Date:  2015-05-14       Impact factor: 12.531

6.  Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  L Allyson Checkley; Okkyung Rho; Tricia Moore; Steve Hursting; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2011-07

Review 7.  Obesity, energy balance, and cancer: new opportunities for prevention.

Authors:  Stephen D Hursting; John Digiovanni; Andrew J Dannenberg; Maria Azrad; Derek Leroith; Wendy Demark-Wahnefried; Madhuri Kakarala; Angela Brodie; Nathan A Berger
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-03

8.  In vivo detection of a novel endogenous etheno-DNA adduct derived from arachidonic acid and the effects of antioxidants on its formation.

Authors:  Ying Fu; Raghu G Nath; Marcin Dyba; Idalia M Cruz; Sharanya R Pondicherry; Aileen Fernandez; Casey L Schultz; Peiying Yang; Jishen Pan; Dhimant Desai; Jacek Krzeminski; Shantu Amin; Plamen P Christov; Yukihiko Hara; Fung-Lung Chung
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

9.  Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencing.

Authors:  Tao Niu; Diane L Smith; Zhen Yang; Song Gao; Taijun Yin; Zhi-Hong Jiang; Ming You; Richard A Gibbs; Joseph F Petrosino; Ming Hu
Journal:  Pharm Res       Date:  2012-12-20       Impact factor: 4.200

10.  Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression.

Authors:  Shumei Song; Koyamangalath Krishnan; Kaifeng Liu; Robert S Bresalier
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.